Aims Implantable device telemonitoring (DTM) is a diagnostic adjunct to traditional face-to-face hospital visits. Remote device follow-up and earlier diagnoses facilitated by DTM should reduce healthcare utilization. We explored whether DTM reduces healthcare utilization over standard of care (SoC), without compromising patient outcomes. Methods and results This systematic review and meta-analysis of 11 randomized controlled trials on DTM in patients with heart failure consisted of 5702 patients, with a median of 117 [interquartile range (IQR) 76-331] patients per study [age 65 years (IQR 63-67)] and follow-up range of 12-36 months. DTM was associated with a reduction in total number of visits [planned, unplanned, and emergency room (ER)] [relative risk (RR) 0.56; 95% confidence interval (CI) 0.43-0.73, P < 0.001]. Rates of cardiac hospitalizations (RR 0.96; 95% CI 0.82-1.12, P = 0.60) and the composite endpoints of ER, unplanned hospital visits, or hospitalizations (RR 0.99; 95% CI 0.68-1.43, P = 0.96) was similar between the DTM and the SoC groups. An increase in the total number of ER or unscheduled visits (RR 1.37; 95% CI 1.11-1.70, P = 0.004) was observed. This effect was consistent and statistically significant for all studies. Total and cardiac mortality were similar between the groups (DTM RR 0.90; 95% CI 0.69-1.16, P = 0.41; and DTM RR 0.93; 95% CI 0.51-1.69, P = 0.80). Monetary costs favoured DTM (10-55% reduction in five studies). Conclusions Compared with SoC, DTM is associated with a marked reduction in planned hospital visits. In addition, DTM was associated with lower monetary costs, despite a modest increase in unplanned hospital and ER visits. DTM did not compromise survival.

Effect of telemonitoring of cardiac implantable electronic devices on healthcare utilization: A meta-analysis of randomized controlled trials in patients with heart failure / Klersy, Catherine; Boriani, Giuseppe; De Silvestri, Annalisa; Mairesse, Georges H.; Braunschweig, Frieder; Scotti, Valeria; Balduini, Anna; Cowie, Martin R.; Leyva, Francisco. - In: EUROPEAN JOURNAL OF HEART FAILURE. - ISSN 1388-9842. - 18:2(2016), pp. 195-204. [10.1002/ejhf.470]

Effect of telemonitoring of cardiac implantable electronic devices on healthcare utilization: A meta-analysis of randomized controlled trials in patients with heart failure

BORIANI, Giuseppe;
2016

Abstract

Aims Implantable device telemonitoring (DTM) is a diagnostic adjunct to traditional face-to-face hospital visits. Remote device follow-up and earlier diagnoses facilitated by DTM should reduce healthcare utilization. We explored whether DTM reduces healthcare utilization over standard of care (SoC), without compromising patient outcomes. Methods and results This systematic review and meta-analysis of 11 randomized controlled trials on DTM in patients with heart failure consisted of 5702 patients, with a median of 117 [interquartile range (IQR) 76-331] patients per study [age 65 years (IQR 63-67)] and follow-up range of 12-36 months. DTM was associated with a reduction in total number of visits [planned, unplanned, and emergency room (ER)] [relative risk (RR) 0.56; 95% confidence interval (CI) 0.43-0.73, P < 0.001]. Rates of cardiac hospitalizations (RR 0.96; 95% CI 0.82-1.12, P = 0.60) and the composite endpoints of ER, unplanned hospital visits, or hospitalizations (RR 0.99; 95% CI 0.68-1.43, P = 0.96) was similar between the DTM and the SoC groups. An increase in the total number of ER or unscheduled visits (RR 1.37; 95% CI 1.11-1.70, P = 0.004) was observed. This effect was consistent and statistically significant for all studies. Total and cardiac mortality were similar between the groups (DTM RR 0.90; 95% CI 0.69-1.16, P = 0.41; and DTM RR 0.93; 95% CI 0.51-1.69, P = 0.80). Monetary costs favoured DTM (10-55% reduction in five studies). Conclusions Compared with SoC, DTM is associated with a marked reduction in planned hospital visits. In addition, DTM was associated with lower monetary costs, despite a modest increase in unplanned hospital and ER visits. DTM did not compromise survival.
2016
27-gen-2016
18
2
195
204
Effect of telemonitoring of cardiac implantable electronic devices on healthcare utilization: A meta-analysis of randomized controlled trials in patients with heart failure / Klersy, Catherine; Boriani, Giuseppe; De Silvestri, Annalisa; Mairesse, Georges H.; Braunschweig, Frieder; Scotti, Valeria; Balduini, Anna; Cowie, Martin R.; Leyva, Francisco. - In: EUROPEAN JOURNAL OF HEART FAILURE. - ISSN 1388-9842. - 18:2(2016), pp. 195-204. [10.1002/ejhf.470]
Klersy, Catherine; Boriani, Giuseppe; De Silvestri, Annalisa; Mairesse, Georges H.; Braunschweig, Frieder; Scotti, Valeria; Balduini, Anna; Cowie, Mar...espandi
File in questo prodotto:
File Dimensione Formato  
ejhf.470.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 260.86 kB
Formato Adobe PDF
260.86 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1139572
Citazioni
  • ???jsp.display-item.citation.pmc??? 46
  • Scopus 96
  • ???jsp.display-item.citation.isi??? 86
social impact